CN Patent
CN105461639B — 一种高纯度马西替坦的精制方法
Assigned to HEFEI JIUNUO MEDICAL TECHNOLOGY Co Ltd · Expires 2018-03-09 · 8y expired
What this patent protects
本发明公开了一种高纯度马西替坦的精制方法,是在避光条件下,将马西替坦粗品用新沸过的溶剂加热溶解,加入活性炭脱色5‑15min,趁热压滤,滤液避光降温至45‑55℃搅拌析晶1‑2h,再降温至20‑30℃搅拌析晶1‑2h,过滤,干燥,得马西替坦纯品。本方法具有操作简捷、收率高、产品纯等优点,收率85%以上,马西替坦纯品纯度在99.9%以上(HPLC检测)。
USPTO Abstract
本发明公开了一种高纯度马西替坦的精制方法,是在避光条件下,将马西替坦粗品用新沸过的溶剂加热溶解,加入活性炭脱色5‑15min,趁热压滤,滤液避光降温至45‑55℃搅拌析晶1‑2h,再降温至20‑30℃搅拌析晶1‑2h,过滤,干燥,得马西替坦纯品。本方法具有操作简捷、收率高、产品纯等优点,收率85%以上,马西替坦纯品纯度在99.9%以上(HPLC检测)。
Drugs covered by this patent
- Opsumit (MACITENTAN) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.